After a year of controversy and complaints, Sen. Elizabeth Warren is asking a federal watchdog to investigate GSK over its ...

Both inhalers provide the advantage of once-daily ... paid by CMS for comparator drugs remain undisclosed. Price Action: GSK stock is up 2.55% at $38.92 at the last check Tuesday.

GSK has developed a new propellant technology for inhaler devices that drastically reduces their use of greenhouse gases, which perhaps surprisingly account for nearly half (49%) of the group’s ...

Eli Lilly CEO Dave Ricks made $114 million last year, according to a new proxy statement, a rare instance of a health ...

A new report says doctors failed to warn patients of the extreme side effects. Patients were not sufficiently worn about “deviant” sexual behavior and other extreme side effects caused by common ...

In this article, we are going to take a look at where GSK plc (NYSE:GSK ... In 2012, there were 3,200 distinct medications under development; by 2022, that number had nearly doubled to 6,100.

Every year, amid Women’s History Month, March 8 marks International Women’s Day—a day dedicated to both honoring past efforts ...

Also Read: GSK's Twice-Yearly Depemokimab Reduces Nasal Polyp Size, Goes Under FDA Review ICER President and CEO Sarah K. Emond emphasized the significance of the report, highlighting that over 15 ...